REINVENTING MEDICINE FOR A HEALTHIER WORLD ULTRA-LONG-ACTING ORAL DOSING IS ACHIEVABLE Lyndra Therapeutics is pioneering the ... first-ever oral, ultra-long-acting, sustained release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily. The Company’s breakthrough Extended-Release Oral Capsule is designed to provide consistent drug levels for an entire week or as long as a month, from one, normal-sized capsule – something no oral therapy has ever achieved before. Lyndra’s robust pipeline is made up of therapies with established and well-known safety profiles across a number of disease areas in which non-adherence is known to be a significant driver of outcomes, including schizophrenia and other central nervous system diseases, diabetes, cardiovascular disease and opioid abuse disorder, among others. The Company is also committed to advancing its platform across new chemical entities and a variety of critical global and public health opportunities alongside partners such as the Bill & Melinda Gates Foundation and the NIH. For more information, visit the Company’s website at www.lyndra.com. At Lyndra, we ask “What if we stopped trying to change the patient and changed the pill instead?" Want to learn more? Please visit our website or contact us at info@lyndra.com. INSPIRED to Join Our Team? Check us out and apply! www.lyndra.com/join-our-team/ At Lyndra Therapeutics, we are INSPIRED by team members who are excited by innovation and growth, demonstrate strong technical expertise, and live our values. We are looking for people who will bring fresh ideas based on experience and who lead by adapting to the fast pace of an emerging biotech. read more